Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 40 in last 24h · 115,255 total before filter · latest 2h ago
40last 24h
1803last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings851M&A104Regulatory25Product16Analyst25
✕ clear all filtersticker: UNHSentiment:bullishneutralbearishshow all (incl. clickbait)
UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands
Simply Wall St.32d agobearish
UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands

The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...

Elevance Is Overcoming Medicare Advantage Hurdles. Earnings Could Show It.
Barrons.com32d agobearish
Elevance Is Overcoming Medicare Advantage Hurdles. Earnings Could Show It.

Elevance Health is breaking the Medicare Advantage curse, and the insurer’s earnings could show it on Wednesday. Health insurer stocks have rallied this year after a tough run of rising medical costs that hampered earnings in 2024 and 2025. The results come just a day ahead of the monster of the industry, UnitedHealth Group Wall Street will be watching to see if these two companies can keep the momentum going.

How To Find Options Trades This Earnings Season
Barchart32d agoneutral
How To Find Options Trades This Earnings Season

Earnings season is here and we’ve got the first batch of big name companies reporting earnings this week with Taiwan Semiconductor, JP Morgan Chase, Wells Fargo, Bank of America, Goldman Sachs and Unitedhealth Group all set to report.

Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks
Barrons.com33d agoneutral
Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks

After a rocky start to the year, health insurer stocks have roared back. The insurers are trying to end a difficult cycle that began about three years ago, when healthcare use, and the costs to cover it, accelerated postpandemic. The fund’s top 10 holdings encompass six health insurers, three of which— UnitedHealth Group Aetna parent CVS Health and Elevance Health —comprise more than 40% of the fund.

Guardant Health stock surges on colon cancer blood test news
TheStreet41d agobullish
Guardant Health stock surges on colon cancer blood test news

Guardant Health (GH) investors have a new number to think about this week. Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175. Bernstein also kept its Outperform rating intact. The new price target came less than a day after a ...

VTV’s Next 12 Months Hinge on One Fed Inflation Signal: Here’s What to Watch
24/7 Wall St.44d agoneutral
VTV’s Next 12 Months Hinge on One Fed Inflation Signal: Here’s What to Watch

The Vanguard Value ETF (NYSEARCA:VTV) has turned into one of the best large-cap stories of 2026, trading near $218 with a 16% year-to-date gain and a 27% advance over the past year. That run rests on a narrow set of legs: a healthcare snapback led by UnitedHealth, a financial-sector grind led by JPMorgan, and energy ... VTV’s Next 12 Months Hinge on One Fed Inflation Signal: Here’s What to Watch

JPMorgan resets UnitedHealth stock target for 2026
TheStreet65d agoneutral
JPMorgan resets UnitedHealth stock target for 2026

As of one year ago, UnitedHealth Group (UNH) was experiencing a severe and volatile downward correction, trading at approximately $300 to $312 per share. Down from its all-time closing high of $603.20 in November, 2024. The CEO, Andrew Witty, had suddenly stepped down, the company pulled its ...